Is the vIL-10 Protein from Cytomegalovirus Associated with the Potential Development of Acute Lymphoblastic Leukemia?

Leukemia is a hematologic malignancy; acute lymphoblastic leukemia (ALL) is the most prevalent subtype among children rather than in adults. <i>Orthoherpesviridae</i> family members produce proteins during latent infection phases that may contribute to cancer development. One such protei...

Full description

Saved in:
Bibliographic Details
Main Authors: Ruvalcaba-Hernández Pamela, Mata-Rocha Minerva, Cruz-Muñoz Mario Ernesto, Mejía-Aranguré Juan Manuel, Sánchez-Escobar Norberto, Arenas-Huertero Francisco, Melchor-Doncel de la Torre Silvia, Rangel-López Angélica, Jiménez-Hernández Elva, Nuñez-Enriquez Juan Carlos, Ochoa Sara, Xicohtencatl-Cortes Juan, Cruz-Córdova Ariadnna, Figueroa-Arredondo Paula, Arellano-Galindo José
Format: Article
Language:English
Published: MDPI AG 2025-03-01
Series:Viruses
Subjects:
Online Access:https://www.mdpi.com/1999-4915/17/3/435
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850276731388166144
author Ruvalcaba-Hernández Pamela
Mata-Rocha Minerva
Cruz-Muñoz Mario Ernesto
Mejía-Aranguré Juan Manuel
Sánchez-Escobar Norberto
Arenas-Huertero Francisco
Melchor-Doncel de la Torre Silvia
Rangel-López Angélica
Jiménez-Hernández Elva
Nuñez-Enriquez Juan Carlos
Ochoa Sara
Xicohtencatl-Cortes Juan
Cruz-Córdova Ariadnna
Figueroa-Arredondo Paula
Arellano-Galindo José
author_facet Ruvalcaba-Hernández Pamela
Mata-Rocha Minerva
Cruz-Muñoz Mario Ernesto
Mejía-Aranguré Juan Manuel
Sánchez-Escobar Norberto
Arenas-Huertero Francisco
Melchor-Doncel de la Torre Silvia
Rangel-López Angélica
Jiménez-Hernández Elva
Nuñez-Enriquez Juan Carlos
Ochoa Sara
Xicohtencatl-Cortes Juan
Cruz-Córdova Ariadnna
Figueroa-Arredondo Paula
Arellano-Galindo José
author_sort Ruvalcaba-Hernández Pamela
collection DOAJ
description Leukemia is a hematologic malignancy; acute lymphoblastic leukemia (ALL) is the most prevalent subtype among children rather than in adults. <i>Orthoherpesviridae</i> family members produce proteins during latent infection phases that may contribute to cancer development. One such protein, viral interleukin-10 (vIL-10), closely resembles human interleukin-10 (IL-10) in structure. Research has explored the involvement of human cytomegalovirus (hCMV) in the pathogenesis of ALL. However, the limited characterization of its latent-phase proteins restricts a full understanding of the relationship between hCMV infection and leukemia progression. Studies have shown that hCMV induces an inflammatory response during infection, marked by the release of cytokines and chemokines. Inflammation may, therefore, play a role in how hCMV contributes to oncogenesis in pediatric ALL, possibly mediated by latent viral proteins. The classification of a virus as oncogenic is based on its alignment with cancer’s established hallmarks. Viruses can manipulate host cellular mechanisms, causing dysregulated cell proliferation, evasion of apoptosis, and genomic instability. These processes lead to mutations, chromosomal abnormalities, and chronic inflammation, all of which are vital for carcinogenesis. This study aims to investigate the role of vIL-10 during the latent phase of hCMV as a potential factor in leukemia development.
format Article
id doaj-art-ac64a1e5d55a4d9aaf6e8e1eb7dc4a6c
institution OA Journals
issn 1999-4915
language English
publishDate 2025-03-01
publisher MDPI AG
record_format Article
series Viruses
spelling doaj-art-ac64a1e5d55a4d9aaf6e8e1eb7dc4a6c2025-08-20T01:50:10ZengMDPI AGViruses1999-49152025-03-0117343510.3390/v17030435Is the vIL-10 Protein from Cytomegalovirus Associated with the Potential Development of Acute Lymphoblastic Leukemia?Ruvalcaba-Hernández Pamela0Mata-Rocha Minerva1Cruz-Muñoz Mario Ernesto2Mejía-Aranguré Juan Manuel3Sánchez-Escobar Norberto4Arenas-Huertero Francisco5Melchor-Doncel de la Torre Silvia6Rangel-López Angélica7Jiménez-Hernández Elva8Nuñez-Enriquez Juan Carlos9Ochoa Sara10Xicohtencatl-Cortes Juan11Cruz-Córdova Ariadnna12Figueroa-Arredondo Paula13Arellano-Galindo José14Laboratorio de Virología, Unidad de Investigación en Enfermedades Infecciosas, Hospital Infantil de México Federico Gómez, Mexico City 06720, MexicoUnidad de Investigación en Genética Humana, Hospital de Pediatría, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Avenida Cuauhtémoc 330, Doctores, Ciudad de México 06720, MexicoFacultad de Medicina, Universidad Autónoma del Estado de Morelos, Cuernavaca 62209, MexicoLaboratorio de Genómica Funcional del Cáncer, Instituto Nacional de Medicina Genómica (INMEGEN), Mexico City 14610, MexicoUnidad de Investigación en Genética Humana, Hospital de Pediatría, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Avenida Cuauhtémoc 330, Doctores, Ciudad de México 06720, MexicoLaboratorio de Investigación en Patología Experimental, Hospital Infantil de México Federico Gómez, Ciudad de México 06720, MexicoLaboratorio de Virología, Unidad de Investigación en Enfermedades Infecciosas, Hospital Infantil de México Federico Gómez, Mexico City 06720, MexicoLaboratorio de Virología, Unidad de Investigación en Enfermedades Infecciosas, Hospital Infantil de México Federico Gómez, Mexico City 06720, MexicoDepartamento de Oncología, Hospital Pediátrico Moctezuma SEDESA, Universidad Autónoma Metropolitana, Mexico City 09769, MexicoUnidad de Investigación Médica en Epidemiología Clínica, Hospital de Pediatría, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City 06720, MexicoLaboratorio de Bacteriología Intestinal, Hospital Infantil de México Federico Gómez, Mexico City 06720, MexicoLaboratorio de Bacteriología Intestinal, Hospital Infantil de México Federico Gómez, Mexico City 06720, MexicoLaboratorio de Inmunoquímica, Hospital Infantil de México Federico Gómez, Mexico City 06720, MexicoEscuela Superior de Medicina del Instituto Politécnico Nacional, Mexico City 11340, MexicoLaboratorio de Virología, Unidad de Investigación en Enfermedades Infecciosas, Hospital Infantil de México Federico Gómez, Mexico City 06720, MexicoLeukemia is a hematologic malignancy; acute lymphoblastic leukemia (ALL) is the most prevalent subtype among children rather than in adults. <i>Orthoherpesviridae</i> family members produce proteins during latent infection phases that may contribute to cancer development. One such protein, viral interleukin-10 (vIL-10), closely resembles human interleukin-10 (IL-10) in structure. Research has explored the involvement of human cytomegalovirus (hCMV) in the pathogenesis of ALL. However, the limited characterization of its latent-phase proteins restricts a full understanding of the relationship between hCMV infection and leukemia progression. Studies have shown that hCMV induces an inflammatory response during infection, marked by the release of cytokines and chemokines. Inflammation may, therefore, play a role in how hCMV contributes to oncogenesis in pediatric ALL, possibly mediated by latent viral proteins. The classification of a virus as oncogenic is based on its alignment with cancer’s established hallmarks. Viruses can manipulate host cellular mechanisms, causing dysregulated cell proliferation, evasion of apoptosis, and genomic instability. These processes lead to mutations, chromosomal abnormalities, and chronic inflammation, all of which are vital for carcinogenesis. This study aims to investigate the role of vIL-10 during the latent phase of hCMV as a potential factor in leukemia development.https://www.mdpi.com/1999-4915/17/3/435vIL10ALL (Acute lymphoblastic leukemia)hCMV (Cytomegalovirus)latent proteins
spellingShingle Ruvalcaba-Hernández Pamela
Mata-Rocha Minerva
Cruz-Muñoz Mario Ernesto
Mejía-Aranguré Juan Manuel
Sánchez-Escobar Norberto
Arenas-Huertero Francisco
Melchor-Doncel de la Torre Silvia
Rangel-López Angélica
Jiménez-Hernández Elva
Nuñez-Enriquez Juan Carlos
Ochoa Sara
Xicohtencatl-Cortes Juan
Cruz-Córdova Ariadnna
Figueroa-Arredondo Paula
Arellano-Galindo José
Is the vIL-10 Protein from Cytomegalovirus Associated with the Potential Development of Acute Lymphoblastic Leukemia?
Viruses
vIL10
ALL (Acute lymphoblastic leukemia)
hCMV (Cytomegalovirus)
latent proteins
title Is the vIL-10 Protein from Cytomegalovirus Associated with the Potential Development of Acute Lymphoblastic Leukemia?
title_full Is the vIL-10 Protein from Cytomegalovirus Associated with the Potential Development of Acute Lymphoblastic Leukemia?
title_fullStr Is the vIL-10 Protein from Cytomegalovirus Associated with the Potential Development of Acute Lymphoblastic Leukemia?
title_full_unstemmed Is the vIL-10 Protein from Cytomegalovirus Associated with the Potential Development of Acute Lymphoblastic Leukemia?
title_short Is the vIL-10 Protein from Cytomegalovirus Associated with the Potential Development of Acute Lymphoblastic Leukemia?
title_sort is the vil 10 protein from cytomegalovirus associated with the potential development of acute lymphoblastic leukemia
topic vIL10
ALL (Acute lymphoblastic leukemia)
hCMV (Cytomegalovirus)
latent proteins
url https://www.mdpi.com/1999-4915/17/3/435
work_keys_str_mv AT ruvalcabahernandezpamela isthevil10proteinfromcytomegalovirusassociatedwiththepotentialdevelopmentofacutelymphoblasticleukemia
AT matarochaminerva isthevil10proteinfromcytomegalovirusassociatedwiththepotentialdevelopmentofacutelymphoblasticleukemia
AT cruzmunozmarioernesto isthevil10proteinfromcytomegalovirusassociatedwiththepotentialdevelopmentofacutelymphoblasticleukemia
AT mejiaarangurejuanmanuel isthevil10proteinfromcytomegalovirusassociatedwiththepotentialdevelopmentofacutelymphoblasticleukemia
AT sanchezescobarnorberto isthevil10proteinfromcytomegalovirusassociatedwiththepotentialdevelopmentofacutelymphoblasticleukemia
AT arenashuerterofrancisco isthevil10proteinfromcytomegalovirusassociatedwiththepotentialdevelopmentofacutelymphoblasticleukemia
AT melchordonceldelatorresilvia isthevil10proteinfromcytomegalovirusassociatedwiththepotentialdevelopmentofacutelymphoblasticleukemia
AT rangellopezangelica isthevil10proteinfromcytomegalovirusassociatedwiththepotentialdevelopmentofacutelymphoblasticleukemia
AT jimenezhernandezelva isthevil10proteinfromcytomegalovirusassociatedwiththepotentialdevelopmentofacutelymphoblasticleukemia
AT nunezenriquezjuancarlos isthevil10proteinfromcytomegalovirusassociatedwiththepotentialdevelopmentofacutelymphoblasticleukemia
AT ochoasara isthevil10proteinfromcytomegalovirusassociatedwiththepotentialdevelopmentofacutelymphoblasticleukemia
AT xicohtencatlcortesjuan isthevil10proteinfromcytomegalovirusassociatedwiththepotentialdevelopmentofacutelymphoblasticleukemia
AT cruzcordovaariadnna isthevil10proteinfromcytomegalovirusassociatedwiththepotentialdevelopmentofacutelymphoblasticleukemia
AT figueroaarredondopaula isthevil10proteinfromcytomegalovirusassociatedwiththepotentialdevelopmentofacutelymphoblasticleukemia
AT arellanogalindojose isthevil10proteinfromcytomegalovirusassociatedwiththepotentialdevelopmentofacutelymphoblasticleukemia